"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 40 | 41 |
| 1996 | 0 | 37 | 37 |
| 1997 | 3 | 54 | 57 |
| 1998 | 0 | 71 | 71 |
| 1999 | 2 | 81 | 83 |
| 2000 | 1 | 67 | 68 |
| 2001 | 3 | 99 | 102 |
| 2002 | 1 | 102 | 103 |
| 2003 | 1 | 148 | 149 |
| 2004 | 1 | 177 | 178 |
| 2005 | 2 | 190 | 192 |
| 2006 | 4 | 216 | 220 |
| 2007 | 3 | 263 | 266 |
| 2008 | 1 | 274 | 275 |
| 2009 | 1 | 287 | 288 |
| 2010 | 3 | 366 | 369 |
| 2011 | 2 | 423 | 425 |
| 2012 | 1 | 368 | 369 |
| 2013 | 2 | 467 | 469 |
| 2014 | 2 | 441 | 443 |
| 2015 | 1 | 418 | 419 |
| 2016 | 7 | 468 | 475 |
| 2017 | 5 | 519 | 524 |
| 2018 | 3 | 500 | 503 |
| 2019 | 1 | 456 | 457 |
| 2020 | 2 | 488 | 490 |
| 2021 | 5 | 427 | 432 |
| 2022 | 0 | 367 | 367 |
| 2023 | 0 | 332 | 332 |
| 2024 | 0 | 392 | 392 |
| 2025 | 0 | 25 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial. J Cachexia Sarcopenia Muscle. 2025 Apr; 16(2):e13750.
-
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.
-
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes. Blood. 2025 Mar 13; 145(11):1126-1135.
-
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium. Blood Adv. 2025 Mar 11; 9(5):1013-1023.
-
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis. Blood Adv. 2025 Mar 11; 9(5):1232-1241.
-
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood Adv. 2025 Mar 11; 9(5):955-965.
-
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement. Blood Adv. 2025 Mar 11; 9(5):1171-1180.
-
Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations. Cancer Discov. 2025 Mar 03; 15(3):511-529.
-
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. Haematologica. 2025 Mar 01; 110(3):608-620.
-
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. Haematologica. 2025 Mar 01; 110(3):706-714.